- Published
- Last updated
A newsletter about cannabis and cannabinoids as medicine
- Published
- Last updated
IACM-Bulletin of 17 March 2024
Read more →Science/Human: Cannabis may be very effective in the treatment of migraine
In an online survey with 1373 patients from a tertiary headache center 56% reported the use of cannabis-based products in the past 3 years and 33% indicated current use. Investigators of Hartford HealthCare Headache Center of the Ayer Neuroscience Institute in West Hartford, USA, noted that this is the largest study to date to document cannabis product usage patterns and perceived benefits for migraine management in a clinical headache patient sample.
- Published
- Last updated
IACM-Bulletin of 10 March 2024
Read more →Science/Human: Cannabis may improve quality of life in patients with chronic illnesses
A survey from Germany with 1030 chronically ill patients showed, that cannabis treatment improved their quality of life regardless of the underlying illness. A standardized questionnaire was presented online nationwide over a 15-week period. Recruitment was supported by pharmacies, prescribing physicians, and patient associations in Germany.
- Published
- Last updated
IACM-Bulletin of 3 March 2024
Read more →Science/Human: Inhaled cannabis may help against acute migraine according to a placebo-controlled study
According to a 4-arm placebo-controlled study with 92 participants cannabis reduced migraine pain. Investigators of the University of California in San Diego, USA, treated adults with migraine up to 4 separate migraine attacks, 1 each with vaporized cannabis flowers with 6% THC, with 11% CBD, with 6% THC+11% CBD, and a placebo in a randomized order. The primary endpoint was pain relief and secondary endpoints were pain freedom and most bothersome symptom freedom, all assessed at 2 hours post-vaporization.
- Published
- Last updated
IACM-Bulletin of 25 February 2024
Read more →IACM: IACM Meeting and Cannabis Talk
Since the IACM conference in April 2024 cannot take place in Aberdeen, UK, as planned, we want to use this time on April 12 and 13 for an online meeting that interested parties from different time zones can attend from the comfort of their own homes. On both days, the program will last about 4.5 hours, during which we will discuss several topics in different formats, including the endocannabinoid system, effects of cannabis beyond THC and CBD, benefits and risks in psychiatric disorders.
- Published
- Last updated
IACM-Bulletin of 18 February 2024
Read more →🌐Europe: Citizen initiative for the improvement of access to the medical use of cannabis
The European Commission agreed to register a multi-national initiative to foster access to the medical use of cannabis and promote research into the therapeutic potential of the plant. That means signature-gathering can get underway. Petitioners will have six months to start the drive, then must gather one million signatures from at least seven member countries within a year to force the European Union to consider the proposal.
- Published
- Last updated
IACM-Bulletin of 11 February 2024
Read more →Science/Human: CBD reduces brain temperature in the seizure onset zone of patients with epilepsy
Investigators of the Department of Neurology at the University of Alabama at Birmingham, USA investigated 25 participants with magnetic resonance spectroscopic imaging approximately 12-weeks apart. Eight patients with treatment resistant epilepsy were imaged before receiving Epidiolex, a CBD rich cannabis extract, and after 12 weeks of CBD therapy. Treatment was started at a daily dose of 5 mg/kg, with bi-weekly titration based on response and tolerability. Seventeen healthy controls were also imaged twice.
- Published
- Last updated
IACM-Bulletin of 4 February 2024
Read more →Science/Human: Cannabis may be helpful in back pain
According to a survey with 259 patients the medical use of cannabis was helpful in the treatment of back or neck pain. Investigators of the Division of Orthopedic Surgery in Kingston, Canada, and other hospitals from Canada analysed data gathered from patients treated by orthopaedic clinics in Ontario.
- Published
- Last updated
IACM-Bulletin of 28 January 2024
Read more →Science/Human: CBD may reduce symptoms in infantile epileptic spasms syndrome
Pure CBD may be helpful in the treatment of about two thirds of children with treatment-resistant epileptic spasms syndrome. Investigators of several hospitals in Argentine conducted a retrospective analysis of clinical records of 28 children aged 6 to 21 months, who received CBD between 2021 and 2023. The cause was structural in 10, Down syndrome in seven, genetic in nine, and unknown in two. Initial CBD dose was 2 mg/kg/day, which was uptitrated to a median dose of 25 mg/kg/day.
- Published
- Last updated
IACM-Bulletin of 21 January 2024
Read more →Science/Human: Cannabis may be effective in the treatment of major depressive disorder
According to a retrospective analysis of data from 59 patients with major depressive disorder cannabis may reduce symptom severity, investigators of the Department of Psychiatry and Psychotherapy at the University of Essen, Germany, and other German institutions reported. treatment was conducted via a telemedical platform and patients were followed for 18 weeks.
- Published
- Last updated
IACM-Bulletin of 14 January 2024
Read more →Science/Human: Cannabis use in schizophrenia may be associated with different effects on aspects of cognition
investigators of the Faculty of Medicine and Pharmacy at Hassan II University in Casablanca, Morocco, compared two groups of patients diagnosed with schizophrenia, 50 cannabis users and 49 non-users .
- Published
- Last updated
IACM-Bulletin of 7 January 2024
Read more →IACM: The newsletter will be published weekly in future
The IACM Bulletin has been published every two weeks since 2000. The number of publications has increased considerably during this time. To ensure that the information in each newsletter remains manageable, we want to increase the frequency of publication. The content will also be adapted. In future, there will be references to interesting review articles. On the other hand, there will be fewer articles on basic research, particularly on studies with few new findings. In this way, the real news will be emphasized. We hope that you find this helpful.
- Published
- Last updated
IACM-Bulletin of 31 December 2023
Read more →🌐Ukraine: Parliament backs the legalisation of cannabis for medical use, but the bill is blocked by an opposition party
Ukraine’s Batkivshchyna (Fatherland) parliamentary faction has blocked the signing of a bill legalizing the use of medical cannabis, which was approved by the 248 deputies of the Ukrainian Verkhovna Rada, the Ukrainian parliament, on 21 December. The bill will remain blocked until mid-January when it may potentially be unblocked by the parliament and signed by the president. "And since the law will come into force only in six months, it will start working around July 2024," Member of Parliament Jaroslav Zalizniak wrote on Telegram.